Belimumab Maintenance Fails to Delay Relapse in AAV Patients, Phase 3 Trial Suggests
News
A combination of belimumab plus standard maintenance treatment is no better than standard of care alone at delaying relapse in ANCA-associated vasculitis (AAV) patients in remission, a Phase 3 clinical trial shows. ... Read more